prikaz prve stranice dokumenta Renal thromboembolism during treatment with recombinant activated factor VII (rFVIIa) in a child with hemophilia B with factor IX inhibitors
  Download
PDF 1.41 MB
Scientific paper - Original scientific paper
Renal thromboembolism during treatment with recombinant activated factor VII (rFVIIa) in a child with hemophilia B with factor IX inhibitors
BMC Pediatrics, 14 (2014); 315. https://doi.org/10.1186/s12887-014-0315-2
Milošević, Danko; Bilić, Ernest; Batinić, Danica; Poropat, Mirjana; Štern-Padovan, Ranka; Galić, Slobodan; Turudić, Daniel

Cite this document

Milošević, D., Bilić, E., Batinić, D., Poropat, M., Štern Padovan, R., Galić, S. & Turudić, D. (2014). Renal thromboembolism during treatment with recombinant activated factor VII (rFVIIa) in a child with hemophilia B with factor IX inhibitors. BMC Pediatrics, 14., 315. doi: 10.1186/s12887-014-0315-2

Milošević, Danko, et al. "Renal thromboembolism during treatment with recombinant activated factor VII (rFVIIa) in a child with hemophilia B with factor IX inhibitors." BMC Pediatrics, vol. 14, 2014, p. 315. https://doi.org/10.1186/s12887-014-0315-2

Milošević, Danko, Ernest Bilić, Danica Batinić, Mirjana Poropat, Ranka Štern Padovan, Slobodan Galić and Daniel Turudić. "Renal thromboembolism during treatment with recombinant activated factor VII (rFVIIa) in a child with hemophilia B with factor IX inhibitors." BMC Pediatrics 14 (2014): 315. https://doi.org/10.1186/s12887-014-0315-2

Milošević, D., et al. (2014) 'Renal thromboembolism during treatment with recombinant activated factor VII (rFVIIa) in a child with hemophilia B with factor IX inhibitors', BMC Pediatrics, 14, p. 315. doi: 10.1186/s12887-014-0315-2

Milošević D, Bilić E, Batinić D, Poropat M, Štern Padovan R, Galić S, and sur.. Renal thromboembolism during treatment with recombinant activated factor VII (rFVIIa) in a child with hemophilia B with factor IX inhibitors. BMC Pediatrics [Internet]. 2014 December 17 [cited 2024 November 14];14:315. doi: 10.1186/s12887-014-0315-2

D. Milošević, et al., "Renal thromboembolism during treatment with recombinant activated factor VII (rFVIIa) in a child with hemophilia B with factor IX inhibitors", BMC Pediatrics, vol. 14, p. 315, December 2014. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:223334. [Accessed: 14 November 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)Renal thromboembolism during treatment with recombinant activated factor VII (rFVIIa) in a child with hemophilia B with factor IX inhibitors
AuthorDanko Milošević
AuthorErnest Bilić
AuthorDanica Batinić
AuthorMirjana Poropat
AuthorRanka Štern-Padovan
AuthorSlobodan Galić
AuthorDaniel Turudić
Author's institutionUniversity of Zagreb
School of Medicine
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract (english)
BACKGROUND: Serious thromboembolic events connected with rFVIIa therapy in hemophilia patients are rare. Only three cases are reported in children, all of them with hemophilia A. ----- CASE PRESENTATION: We present unique case of patient with hemophilia B and high titer inhibitors to coagulation FIX, who developed severe renal damage due to thromboembolic event during rFVIIa therapy, associated with unsuspected renovascular anomalies. ----- CONCLUSION: Caution is necessary if hematuria B requires administration of rFVIIa. US color doppler renal imaging before and after drug administration should be sufficient as an early warning.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleBMC Pediatrics
Numberingvol. 14, p. 315
p-ISSN1471-2431
DOIhttps://doi.org/10.1186/s12887-014-0315-2
URN:NBNurn:nbn:hr:105:223334
Publication2014-12-17
Document URLhttp://doi.org/10.1186/s12887-014-0315-2
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2024-03-28 08:30:05